Rene Lenobel
senior researcher
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (10)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
A series of eight N ‐heterocyclic carbenes (NHC) gold(I) complexes, involving 1,3‐bis(2,6‐diisopropylphenyl)imidazol‐2‐ylidene (iPr) ligand in combination with 6‐mercaptopurine derivatives (HL 1–8 ), has been prepared and thoroughly characterized, including elemental analysis, mass spectrometry, infrared and multinuclear NMR spectroscopy, and single crystal X‐ray analysis. The complexes, showing general composition of [Au (iPr)(L n )] 1 – 8 , were evaluated for their in vitro cytotoxicity against four human cancer cell lines including A2780 (ovarian) and A2780R (ovarian Cisplatin resistant), PC3 (prostate) and MCF‐7 (breast), and normal human MRC‐5 cells (lung fibroblasts). The complexes revealed significant cytotoxicity, with the best IC 50 values ≈ 3.4–6.4 μM against A2780 and reasonable selectivity. Cellular effects of the selected complexes on the A2780 cells were evaluated using various flow cytometry assays. Complexes 1 , 3 , and 4 showed a strong pro‐apoptotic effect and a strong effect on the loss of mitochondrial membrane potential. These findings indicate that their major mechanism of action is based on the collapse of the mitochondrial metabolism and activation of the intrinsic signaling pathway of apoptosis, consequently resulting in cell death. The complexes 1 – 8 revealed only negligible effect on the production of inflammatory‐related cytokine (TNF‐α), as well as the activation of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) or peroxisome proliferator‐activated receptor gamma (PPARγ). Moreover, the shotgun proteomic analysis was performed, and the obtained results suggest that the mechanism of action of complexes 1 , 3 , and 4 differs somewhat from that of Auranofin .
Year:
2024
Year:
2024
Year:
2023
Collaborators (26)
Asta Žukauskaitė
Palacký University, Olomouc
Filipp Georgijevic Savvulidi
Assistant professor / Ing., Ph.D
Czech University of Life Sciences Prague
Ioanna Antoniadi
Researcher
Swedish University of Agricultural Sciences
Monika Chodasiewicz
Assistant Professor
King Abdullah University of Science and Technology
Jan Skalák
Mendel University in Brno
Marek Rác
Palacký University
Petr Bednar
Associate Professor
Palacký University, Olomouc
Petr Tarkowski
Group leader
Palacký University
Jan Hejatko
professor
Masaryk University
Martina Špundová
associate professor
Univerzita Palackého v Olomouci
Andrew Nelson
Associate Professor
Boyce Thompson Institute
Martin Hudeček
Czech Academy of Sciences, Institute of Botany
Ankush Prasad
Associate Professor
Palacký University, Olomouc
Petr Smykal
Professor
Univerzita Palackého v Olomouci
Marek Sebela
Professor
Palacký University Olomouc, Faculty of Science
Miroslav Strnad
Head of Laboratory of Growth Regulators
Czech Academy of Sciences
Karin Ljung
Swedish University of Agricultural Sciences
Jan Hošek
associate professor
Masaryk University
Jan Vanco
Docent
Palacký University, Olomouc
Sanja Cavar Zeljkovic
Crop Research Institute
Marek Petřivalský
Professor, Head of Department
Palacký University, Olomouc
Zdeněk Dvořák
Palacký University, Olomouc
Aleksandra Skirycz
Associate Professor
Michigan State University
Annette Rompel
Universität Wien
Pavel Pospíšil
Associate Professor, Ph.D.
Palacký University, Olomouc
Vít Herynek
Charles University, First Faculty of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.